Clinical & Diagnostic
Sun Pharma and Philogen Sign Exclusive Agreement for NIDLEGY™ Commercialization in Europe, Australia, and New Zealand
Under the terms of the agreement, Sun Pharma will have exclusive rights to commercialise Nidlegy™ for indications of skin cancers in the territories ...
May 31, 2023 | News
Menarini Group's ORSERDU® (Elacestrant) Study Advances in Metastatic Breast Cancer
ORSERDU (elacestrant) was approved by the FDA in January 2023 for advanced or metastatic estrogen receptor (ER)-positive, human epidermal growth factor (...
May 30, 2023 | News
Hospital-Based Health Technology Assessment: Global Experience and Vietnam's Situation
From the perception and vision, from May 26th to May 27th, Hong Bang International University (HIU) collaborated with the Vietnam Medical As...
May 30, 2023 | News
AMP945 and FOLFIRINOX Synergize for Enhanced Pancreatic Cancer Treatment
Amplia's highly selective FAK inhibitor AMP945, when used in combination with FOLFIRINOX, enhances survival in a preclinical model of pancreatic ...
May 30, 2023 | News
FivepHusion partners with Treehill Partners and Syneos Health for strategic collaboration
FivepHusion, an advanced clinical-stage biotechnology company, today announced its collaboration with Treehill Partners, a New York-based strategic an...
May 29, 2023 | News
HanAll Biopharma, Daewoong Pharmaceutical, and NurrOn Pharma Collaborate on Parkinson's Therapy
HanAll Biopharma Co., Ltd. (KRX: 009420.KS) and Daewoong Pharmaceutical Co., Ltd. (KRX: 069620.KS) announced that they have entered into a co-developm...
May 26, 2023 | News
Daewoong Pharmaceutical Reveals Bersiporocin's Antifibrotic Mechanism
Daewoong Pharmaceutical (CEO Lee Chang-jae and Jeon Sengho) announced on the 25th that the molecular mechanism behind safety and efficacy of Bersiporo...
May 26, 2023 | News
Antengene's ATG-022 Receives Orphan Drug Designations for Gastric and Pancreatic Cancers
Orphan Drugs, also known as Rare Disease Drugs, refers to pharmaceutical products developed for the prevention, diagnosis, and treatment of rare diseases o...
May 24, 2023 | News
Asieris and UroViu Strengthen Partnership for Bladder Cancer Diagnosis and Treatment Platform
Under the agreement, Asieris Pharmaceuticals will use this patented technology in combination with specific optical imaging agents to conduct research on t...
May 19, 2023 | News
Hummingbird Bioscience, Merck to Evaluate HMBD-001 in Lung Carcinoma
Hummingbird Bioscience enters a clinical trial collaboration and supply agreement with Merck to evaluate HMBD-001, a potentially best-in-class anti-HER3 ...
May 16, 2023 | News
CytoMed collaborates with MD Anderson to advance Gamma Delta T Cells in Oncology
CytoMed Therapeutics Limited (Nasdaq: GDTC) ("CytoMed" or the "Company"), a biopharmaceutical company focused on harnessing its licensed proprietary techno...
May 11, 2023 | News
Lucence Launches LucenceINSIGHT to Detect Cancer Earlier
Lucence achieved a significant milestone in February 2023 as the first Asian company to secure Medicare coverage in the US for LiquidHALLMARK, its Singapor...
May 11, 2023 | News
Thermo Fisher & Pfizer team up to bring cancer testing to global markets
Increasing localized access can provide faster results for patients while potentially improving patient outcomes Agreement aims to enable greater access t...
May 10, 2023 | News
Singapore Approves New Therapy for Rare Gastrointestinal Stromal Tumors
Singapore's Health Sciences Authority (HSA) has approved QINLOCK® (ripretinib) for the treatment of patients with 4th line GIST QINLO...
May 08, 2023 | News
Most Read
- 25 Biopharma Leaders Shaping a Sustainable 2025: Innovation Meets Environmental Responsibility
- 25 Leading AI Companies to Watch in 2025: Transforming Drug Discovery and Precision Medicine
- Mr. Brendan O’Callaghan Discusses Sanofi’s Singapore Modulus Facility: Advancing Biopharma Manufacturing and Pandemic Preparedness
- Shaping the Future of PCV Care: Insights from Roche’s Stefan Scheidl on the SALWEEN Trial
- Pam Cheng Outlines AstraZeneca’s Bold Vision for Singapore’s First End-to-End ADC Manufacturing Facility
- Shaping a Health Innovation Hub: Alessandro Falcone Reflects on JLABS Singapore’s Milestone Year and Future Goals
Bio Jobs
- Avance Clinical Appoints Jessica Han as Director of Asian Operations, Strengthening Commitment to the Asian Market
- Bristol Myers Squibb Employees Cycle Coast-to-Coast to Raise $1 Million for Cancer Research
- Pfizer Australia Commits $150M to Upgrade Melbourne Facility, Bolstering Global Fight Against Antimicrobial Resistance
- SMi Systems Appoints Dr. Stefan Hamill as Vice President of Strategy to Drive Commercialisation and Growth
- Thermo Fisher Scientific Appoints William Hung as Senior Director and General Manager for Taiwan
- Cytiva Appoints Industry Veteran Pierre-Alain Ruffieux as Chief Operating Officer
News
